Dr. Akin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12200 Renfert Way
Suite 100
Austin, TX 78758Phone+1 512-451-8211
Summary
- Dr. Mark Akin is an obstetrician/gynecologist in Austin, TX and is affiliated with St. David's Medical Center. He received his medical degree from University of Texas Southwestern Medical School and has been in practice 43 years. He is experienced in reproductive and sexual endocrinology, general obstetrics and gynecology, uterine fibroids, urinary incontinence and utero-vaginal prolapse, and reproductive genetics. He has 6 publications and over 150 citings.
Education & Training
University of Texas Southwestern Medical CenterResidency, Obstetrics and Gynecology, 1979 - 1983
University of Texas Southwestern Medical SchoolClass of 1979
Certifications & Licensure
TX State Medical License 1979 - 2025- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2012-2013
- Most Compassionate Doctor American Registry
- Super Doctor SuperDoctors.com
- Join now to see all
Publications & Presentations
PubMed
- 4 citationsSafety Run-in of Intramuscular pNGVL4a-Sig/E7(detox)/HSP70 DNA and TA-CIN Protein Vaccination as Treatment for HPV16+ ASC-US, ASC-H, or LSIL/CIN1.Mark H Einstein, Richard B S Roden, Louise Ferrall, Mark Akin, Allison Blomer
Cancer Prevention Research. 2023-04-03 - 2 citationsRate of detecting CIN3+ among patients with ASC-US using digital colposcopy and dynamic spectral imaging.Karen Eloise Harris, Philip T. Lavin, Mark Donnell Akin, Emmanouil Papagiannakis, Sara A DeNardis
Oncology Letters. 2020-10-01 - 62 citationsTreatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial.Jacques Donnez, Hugh S. Taylor, Robert N. Taylor, Mark D. Akin, Tatyana F. Tatarchuk
Fertility and Sterility. 2020-07-01
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
